sales News
Most Popular sales Story
What to do with Avandia sales force?
GlaxoSmithKline may cut or redeploy its Avandia sales force in the wake of safety concerns that have virtually destroyed the drugs sales. Avandia is GSK’s second bestselling drug, earning £1.4... Read more...
Latest Headlines
- August 14, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
